Elkfork Partners’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$245K Hold
6,534
0.01% 772
2019
Q2
$285K Hold
6,534
0.01% 732
2019
Q1
$279K Hold
6,534
0.01% 721
2018
Q4
$293K Hold
6,534
0.01% 676
2018
Q3
$448K Buy
+6,534
New +$420K 0.01% 630
2018
Q2
Sell
-5,104
Closed -$235K 1009
2018
Q1
$235K Hold
5,104
0.01% 742
2017
Q4
$236K Buy
5,104
+792
+18% +$36.4K 0.01% 751
2017
Q3
$194K Buy
4,312
+484
+13% +$20.7K 0.01% 744
2017
Q2
$150K Buy
3,828
+1,738
+83% +$65.7K ﹤0.01% 767
2017
Q1
$80K Buy
2,090
+22
+1% +$857 ﹤0.01% 809
2016
Q4
$76K Buy
+2,068
New +$73.9K ﹤0.01% 802

Other funds holding AVNS

Elkfork Partners's AVNS Position: Q3 2019 in Review

Elkfork Partners held its Avanos Medical (AVNS) position steady in Q3 2019 at 6,534 shares worth $245K. The position accounts for 0.01% of the portfolio, ranked #772.

Elkfork Partners first reported a position in AVNS in Q4 2016 and has held it in 11 quarters since. The position peaked at $448K in Q3 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

  • Elkfork Partners held 6,534 shares of Avanos Medical worth $245K as of Q3 2019.
  • Elkfork Partners left its Avanos Medical share count unchanged in Q3 2019.
  • Avanos Medical made up 0.01% of Elkfork Partners's portfolio in Q3 2019, its #772 holding.
  • Elkfork Partners first reported a position in Avanos Medical in Q4 2016 and has held it in 11 quarters since.
  • Elkfork Partners's Avanos Medical position peaked at $448K in Q3 2018.
  • 290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.